CoChat

Prkar1a is an osteosarcoma tumor suppressor that defines a molecular subclass in mice

Open access
Molyneux, Sam D., Di Grappa, Marco A., Beristain, Alexander G., McKee, Trevor D., Wai, Daniel H., Paderova, Jana, Kashyap, Meenakshi, Hu, Pingzhao, Maiuri, Tamara, Narala, Swami R., Stambolic, Vuk, Squire, Jeremy, Penninger, Josef, Sanchez, Otto, Triche, Timothy J., Wood, Geoffrey A., Kirschner, Lawrence S., Khokha, Rama · 2010 · Journal of Clinical Investigation
Cited by 99

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Abstract

Some cancers have been stratified into subclasses based on their unique involvement of specific signaling pathways. The mapping of human cancer genomes is revealing a vast number of somatic alterations; however, the identification of clinically relevant molecular tumor subclasses and their respective driver genes presents challenges. This information is key to developing more targeted and personalized cancer therapies. Here, we generate a new mouse model of genomically unstable osteosarcoma (OSA) that phenocopies the human disease. Integrative oncogenomics pinpointed cAMP-dependent protein kinase type I, alpha regulatory subunit (Prkar1a) gene deletions at 11qE1 as a recurrent genetic trait for a molecularly distinct subclass of mouse OSA featuring RANKL overexpression. Using mouse genetics, we established that Prkar1a is a bone tumor suppressor gene capable of directing subclass development and driving RANKL overexpression during OSA tumorigenesis. Finally, we uncovered evidence for a PRKAR1A-low subset of human OSA with distinct clinical behavior. Thus, tumor subclasses develop in mice and can potentially provide information toward the molecular stratification of human cancers.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci42391

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 15 references

Cited by

See all 99

Metadata

Authors
Molyneux, S. D., Di Grappa, M. A., Beristain, A. G., McKee, T. D., Wai, D. H., Paderova, J., Kashyap, M., Hu, P., Maiuri, T., Narala, S. R., Stambolic, V., Squire, J., Penninger, J., Sanchez, O., Triche, T. J., Wood, G. A., Kirschner, L. S., & Khokha, R.
Venue
Journal of Clinical Investigation
Published
2010-09-01
Volume
120
Issue
9
Pages
3310-3325
ISSN
0021-9738 (ISSN-L)
OpenAlex
W2028650359
Cited by
99
References
15
FWCI
5.66
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Prkar1a is an osteosarcoma tumor suppressor that defines a molecular subclass in mice. https://app.cochat.ai/papers/10.1172/jci42391
The paper
Molyneux, S. D., Di Grappa, M. A., Beristain, A. G., McKee, T. D., Wai, D. H., Paderova, J., Kashyap, M., Hu, P., Maiuri, T., Narala, S. R., Stambolic, V., Squire, J., Penninger, J., Sanchez, O., Triche, T. J., Wood, G. A., Kirschner, L. S., & Khokha, R. (2010). Prkar1a is an osteosarcoma tumor suppressor that defines a molecular subclass in mice. Journal of Clinical Investigation. https://doi.org/10.1172/jci42391

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.